Acorda Parkinson’s Drug Launched, Exec Hindman Is Now Set to Leave

cafead

Administrator
Staff member
  • cafead   Mar 08, 2019 at 10:12: AM
via Acorda Therapeutics (NASDAQ: ACOR), which has just launched a new Parkinson’s disease treatment, is saying farewell to chief business officer Andrew Hindman.

article source
 

<